Polling Station

Poll 04/10/2019 – 31/10/2019

Choice of antiplatelet therapy around complex revascularisation

A 79-year-old diabetic male patient with no history of coronary disease is referred to you to undergo angioplasty for tissue loss on the tips of the hallux and second toe. He is taking Aspirin 75mg. From preoperative imaging he needs a 20cm SFA occlusion stopping before the adductor hiatus recanalizing as well as multilevel tibial disease which appears to be a combination of short occlusions and stenoses. The dorsal pedal is seen in the foot and is in continuity with the arch. The PT artery appears occluded through it’s whole length.

Question #1

Would you be happy with aspirin 75mg pre-procedurally and would you want him to take it on the day of the procedure?
  • Yes
  • No
  • Switch to another antiplatelet
Question #2

You perform the procedure successfully and primary bare metal stent the SFA because of recoil. What would your choice of the antiplatelet agent be post-procedure?
  • Monotherapy
  • Dual therapy
  • Anticoagulant
Question #3

You perform drug-eluting stenting of the SFA, does this influence your choice of antiplatelet therapy?
  • Yes
  • No
Question #4

You perform atherectomy of the SFA with subsequent antirestenotic therapy. Would this change your practice?
  • Yes
  • No
Question #5

What would you consider the most important factor in postoperative wound healing after this procedure?
  • Patency of angioplasty
  • Drug therapy (all drugs)
  • Compliance with other interventions such as dressings and offloading